| Literature DB >> 20462217 |
Lorna H Mitchell1, Theodore R Johnson, Guang Wei Lu, Daniel Du, Kaushik Datta, Felicity Grzemski, Veerabahu Shanmugasundaram, Julie Spence, Kim Wade, Zhi Wang, Kevin Sun, Kristin Lin, Lain-Yen Hu, Karen Sexton, Neil Raheja, Catherine Kostlan, David Pocalyko.
Abstract
A novel nonsteroidal androgen receptor antagonist, (R)-4-(1-benzyl-4,4-dimethyl-2-oxopyrrolidin-3-yloxy)-2-(trifluoromethyl)benzonitrile (1), for the topical control of sebum production is reported. This compound, which is potent, selective, and efficacious in the clinically validated golden Syrian hamster ear animal model, was designed to be delivered to the pilosebaceous unit, the site of action, preferentially by the follicular route.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20462217 DOI: 10.1021/jm9018004
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446